AIkido Pharma Inc (AIKI)

[postyle]

because at $27 the valuation of SPEX was approximately $500 million, which is not supported by fundamentals in any way shape or form

The market cluelessly was trading SPEX without considering the dilutive effect of the merger with North South

That was then, this is now. Today, on a fully diluted basis, there are approx 26 million shares outstanding. Which gives SPEX a very healthy valuation in the $65 million range. There is upside from here if the company can execute.